drugset / Trial / NCT02361775

Paravertebral Catheters for VATS Procedures

NCT02361775

Phase 0 Completed 50 enrolled University of Minnesota
RandomizedParallel-groupOpen-labelTreatment

Summary

Level I randomized prospective outcomes study comparing two groups of patients. One group will receive Dilaudid patient controlled analgesia (PCA) post-operatively. The other will receive an ultrasound guided paravertebral block with indwelling paravertebral catheter with an infusion of 0.2% Ropivicaine post-operatively and a PCA.

Timeline

Start
2012-07
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 0.2 % Other

Indications

No indication recorded.